Incyte Provides Regulatory Update on Ruxolitinib Extended-Release Tablets

NeuroSense Therapeutics to collaborate with Massachusetts General Hospital's NeuroEpigenetics Lab

DermBiont Touts Phase 2 Trial Data Treating Seborrheic Keratosis with SM-020 Topical Gel

Athersys Reports on Type B Meeting with the US FDA

Incyte receives Japanese approval for Pemazyre to treat myeloid/lymphoid neoplasms

Pharming Group's Joenja receives FDA approval to treat APDS

Axena Health Receives Positive Insurance Coverage Decision from Cigna Healthcare for Leva Pelvic Health System

European Commission Grants Orphan Designation for iECURE's Lead Product Candidate GTP-506 for the Treatment of Ornithine Transcarbamylase Deficiency

Josep Bassaganya-Riera Launches NImmune Biopharma

ONO Pharma USA's Tirabrutinib (ONO-4059) receives FDA Orphan Drug Designation

Creative Medical Technology files FDA Orphan Drug Designation application for ImmCelz(CELZ-100) platform to treat Brittle Type 1 Diabetes

Mitsubishi Tanabe Pharma America completes enrolment for global Phase 3b study of RADICAVA ORS (edaravone) in ALS

Shanghai Henlius Biotech's EMA application for HANSIZHUANG (serplulimab) in combination with chemotherapy receives validation

Cognito Therapeutics Raises USD 73m Series B

Regencor adds Philip Janiak, PhD and Ken Mahaffey, MD to Scientific Advisory Board